These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9416314)

  • 1. Neuroprotective properties of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhaber E; Baethmann A; Reulen HJ
    Acta Neurochir Suppl; 1997; 70():176-8. PubMed ID: 9416314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia.
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Brain Res; 1999 Jan; 816(2):471-9. PubMed ID: 9878871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Plesnila N; Baethmann A; Reulen HJ
    Stroke; 1997 Oct; 28(10):2018-24. PubMed ID: 9341713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Exp Brain Res; 2000 Jan; 130(1):60-6. PubMed ID: 10638441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.
    Soehle M; Heimann A; Kempski O
    Stroke; 1998 Jun; 29(6):1240-6; discussion 1246-7. PubMed ID: 9626300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
    Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL
    Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
    Andrus PK; Fleck TJ; Oostveen JA; Hall ED
    J Neurosci Res; 1997 Mar; 47(6):650-4. PubMed ID: 9089214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury.
    Durmaz R; Ertilav K; Akyüz F; Kanbak G; Bildirici K; Tel E
    J Neurol Sci; 2003 Nov; 215(1-2):87-93. PubMed ID: 14568134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic time window for the 21-aminosteroid, U-74389G, in global cerebral ischemia.
    Lee SH; Kondoh T; Camarata PJ; Heros RC
    Neurosurgery; 1996 Mar; 38(3):517-21; discussion 522. PubMed ID: 8837804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats.
    Zausinger S; Schöller K; Plesnila N; Schmid-Elsaesser R
    Stroke; 2003 Sep; 34(9):2246-51. PubMed ID: 12893947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].
    Engelhard K; Werner C; Lu H; Möllenberg O; Zieglgänsberger W; Kochs E
    Anaesthesist; 2000 Sep; 49(9):816-21. PubMed ID: 11076270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined therapy with hyperbaric oxygen and antioxidant on infarct volume after permanent focal cerebral ischemia.
    Acka G; Sen A; Canakci Z; Yildiz S; Akin A; Uzun G; Cermik H; Yildirim I; Kokpinar S
    Physiol Res; 2007; 56(3):369-373. PubMed ID: 16792474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats.
    Xiong Y; Peterson PL; Muizelaar JP; Lee CP
    J Neurotrauma; 1997 Dec; 14(12):907-17. PubMed ID: 9475372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel pyrrolopyrimidine lipid peroxidation inhibitors U-101033E and U-104067F protect facial motor neurons following neonatal axotomy.
    Smith SL; Oostveen JA; Hall ED
    Exp Neurol; 1996 Oct; 141(2):304-9. PubMed ID: 8812165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the pyrrolopyrimidine lipid peroxidation inhibitor U-101033E on neuronal and astrocytic metabolism and infarct volume in rats with transient middle cerebral artery occlusion.
    Håberg A; Qu H; Hjelstuen MH; Sonnewald U
    Neurochem Int; 2007 Jun; 50(7-8):932-40. PubMed ID: 17241701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia.
    Nito C; Ueda M; Inaba T; Katsura K; Katayama Y
    Neurol Res; 2011 Oct; 33(8):881-9. PubMed ID: 22004713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Neurosurgery; 1999 Jan; 44(1):163-71; discussion 171-2. PubMed ID: 9894977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.